(Reuters) - Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly ...
Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...
This was the stock's second consecutive day of gains.
San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...
2don MSNOpinion
The slain CEO of the insurer had a vision for positive change; his company should embrace new consumer remedies, writes .
Key Takeaways UnitedHealth Group is set to report fourth-quarter earnings before the market opens Thursday.All 17 analysts ...
UnitedHealth Chief Executive Andrew Witty stated the obvious when he wrote last month that no one would design a healthcare ...
UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their ...
Anger at the company, and the health insurance industry more broadly, boiled over last month following the murder of ...
The stock's fall snapped a four-day winning streak.
6don MSN
Shareholders of UnitedHealth Group (UHG) are calling on the company’s board of directors to release a report on how its ...
UNH stock is finally returning to form after UnitedHealthcare CEO Brian Johnson was gunned down outside an investor meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback